Abstract
The coronavirus disease 19 (COVID-19) is a highly pathogenic and transmissible viral disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which originated in the city of Wuhan, Hubei Province, Central China and spread quickly around the world. The genome sequence of SARSCoV- 2 is phylogenetically related to bat-derived severe acute respiratory syndrome-like (SARS-like) coronaviruses; therefore bats could be the possible primary reservoirs. At present, there are no clinically approved vaccines or specific antiviral drugs for COVID- 19. However, several broad-spectrum antiviral drugs have been evaluated against COVID-19 in clinical studies and resulted in the improvement of patients. In this regard, other therapies such as antiviral drugs, antibodies, stem cells and plasma therapy are being studied. In the current study, we reviewed the emergence, pathogenicity and the genome structure of COVID-19 infection. The main focus of this study is on the therapeutic approaches that may be effective against SARS-CoV-2.
Keywords: COVID-19, novel coronavirus, therapeutic, SARS-CoV-2, antiviral, SARS-CoV-19.
Current Molecular Medicine
Title:Therapeutic Measures for the Novel Coronavirus: A Review of Current Status and Future Perspective
Volume: 21 Issue: 7
Author(s): Mahshid Shahverdi and Maryam Darvish*
Affiliation:
- Department of Medical Biotechnology, School of Medicine, Arak University of Medical Sciences, Arak,Iran
Keywords: COVID-19, novel coronavirus, therapeutic, SARS-CoV-2, antiviral, SARS-CoV-19.
Abstract: The coronavirus disease 19 (COVID-19) is a highly pathogenic and transmissible viral disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which originated in the city of Wuhan, Hubei Province, Central China and spread quickly around the world. The genome sequence of SARSCoV- 2 is phylogenetically related to bat-derived severe acute respiratory syndrome-like (SARS-like) coronaviruses; therefore bats could be the possible primary reservoirs. At present, there are no clinically approved vaccines or specific antiviral drugs for COVID- 19. However, several broad-spectrum antiviral drugs have been evaluated against COVID-19 in clinical studies and resulted in the improvement of patients. In this regard, other therapies such as antiviral drugs, antibodies, stem cells and plasma therapy are being studied. In the current study, we reviewed the emergence, pathogenicity and the genome structure of COVID-19 infection. The main focus of this study is on the therapeutic approaches that may be effective against SARS-CoV-2.
Export Options
About this article
Cite this article as:
Shahverdi Mahshid and Darvish Maryam *, Therapeutic Measures for the Novel Coronavirus: A Review of Current Status and Future Perspective, Current Molecular Medicine 2021; 21 (7) . https://dx.doi.org/10.2174/1566524020666201203170230
DOI https://dx.doi.org/10.2174/1566524020666201203170230 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Baculovirus as Vaccine Vectors
Current Gene Therapy Blend U-Net: Redesigning Skip Connections to Obtain Multiscale Features for Lung CT Images Segmentation
Current Medical Imaging Class- and Molecule-specific Differential Effects of Angiotensin II Type 1 Receptor Blockers
Current Pharmaceutical Design Screening of Extremophile Microalgae Isolated from High Background Radiation Areas as Source of Bioactive Materials
Current Bioactive Compounds Diagnosis and Management of Hypertensive Emergencies Complicating Pregnancy
Current Women`s Health Reviews A Review of PCSK9 Inhibitors and their Effects on Cardiovascular Diseases
Current Topics in Medicinal Chemistry Multi-Targeted Histone Deacetylase Inhibitors in Cancer Therapy
Current Medicinal Chemistry Properties and Architecture of Drugs and Natural Products Revisited
Current Chemical Biology Plant Plastid Engineering
Current Genomics QSARs, Data and Error in the Modern Age of Drug Discovery
Current Topics in Medicinal Chemistry Substance P at the Neuro-Immune Crosstalk in the Modulation of Inflammation, Asthma and Antimicrobial Host Defense
Inflammation & Allergy - Drug Targets (Discontinued) Utility of Walk Tests in the Progression of Mild COVID-19 Infection at a Tertiary Hospital in North India
Recent Advances in Anti-Infective Drug Discovery Mimics of Host Defense Proteins; Strategies for Translation to Therapeutic Applications
Current Topics in Medicinal Chemistry Synthesis and Biological Evaluation of Novel Thiazol-2yl-amine Derivatives as Potential Anticancer Agents
Letters in Organic Chemistry Proteomics as a Tool in the Pharmaceutical Drug Design Process
Current Pharmaceutical Design Review of Airway Illnesses by Kytococcus and Rothia and a Look at Inhalatory Vancomycin as a Treatment Support
Recent Patents on Anti-Infective Drug Discovery A Review of Wavelet Denoising in MRI and Ultrasound Brain Imaging
Current Medical Imaging A Novel Pentagonal Shaped Planar Inverted-F Antenna for Defense Applications
Recent Patents on Computer Science Hyperglycaemia and Vitamin D: A Systematic Overview
Current Diabetes Reviews Calprotectin: The Link Between Acute Lung Injury and Gastrointestinal Injury in Covid-19: Ban or Boon
Current Protein & Peptide Science